Techno Trends
Techno Trends includes advancements and innovations in pharmaceutical products and technology from around the world. Additionally, you may keep abreast of any recent advancements in the pharmaceutical industry (product information and technological trends).
Iovance's Groundbreaking AMTAGVI™ (Lifileucel) Secures Accelerated FDA Approval to Revolutionize Advanced Melanoma Therapy
Iovance Biotherapeutics has gained approval from the U.S. Food and Drug Administration for AMTAGVI™ suspension for intravenous infusion. This treatment is tailored for adults facing unresectable or metastatic melanoma...
FDA Approves Mabwell's Innovative Novel B7-H3 ADC 7MW3711 targeting for Clinical Trials
Mabwell, an innovative biopharmaceutical company boasting a comprehensive industry chain, has received approval from the U.S. Food and Drug Administration for its clinical trial application of a novel B7-H3...
Bayer's novel BAY 2927088 Granted FDA Breakthrough Status for HER2-Driven Non-Small Cell Lung Cancer
Bayer made a recent announcement stating that the U.S. Food and Drug Administration has granted Breakthrough Therapy designation for BAY 2927088. This designation is for the treatment of adult patients...
Neurologists at IU Administer received FDA-Approval for First-of-Its-Kind Gene Therapy
Neurologists at the Indiana University School of Medicine have commenced administering a pioneering gene-based therapy for individuals afflicted with a rare variant of amyotrophic lateral sclerosis...
UTEP Researchers Discover Novel Compound with Anti-Leukemia and Anti-Lymphoma Properties
Researchers at The University of Texas at El Paso have identified a groundbreaking pharmaceutical compound that shows promise in eliminating leukemia and lymphoma cancer cells, offering potential advancements in treatment options...
Renovos Biologics Novel RENOVITE® BMP-2 Gel Receives FDA Breakthrough Device Designation
Biocomposites, an international company specializing in medical devices for bone regeneration and infection management, is excited to announce that its affiliated firm, Renovos Biologics, has received Breakthrough Device...
FDA Approves Vanda Pharmaceuticals' Novel Investigational New Drug, VCA-894A, for the Treatment of Charcot-Marie-Tooth Disease, Type 2S
Vanda Pharmaceuticals recently announced a significant achievement: the FDA's approval of their Investigational New Drug application for evaluating VCA-894A in treating patients with Charcot-Marie-Tooth disease,...
NOVOSIS PUTTY a Novel Creation by CGBio, Receives FDA Breakthrough Designation
CGBio, a South Korean specialist in bio-regenerative medicine, announced on the 2nd that its advanced bone substitute material, "NOVOSIS PUTTY," has received the 'Breakthrough Device Designation...
FDA Approves Coherus' Novel UDENYCA ONBODY™ Delivery System for pegfilgrastim-cbqv
Coherus BioSciences, a biopharmaceutical company with a focus on developing innovative immunotherapies for cancer treatment, has received FDA approval for UDENYCA ONBODY™. This on-body injector...
Scientists Introduce Novel Lipid Nanoparticle for Precision mRNA Delivery to Muscles, Mitigating Off-Target Effects
Researchers at the University of Toronto's Leslie Dan Faculty of Pharmacy have revealed a groundbreaking ionizable lipid nanoparticle named iso-A11B5C1. This nanoparticle stands out for its ability to deliver mRNA...
